Thorrington D, et al. - An estimation was conducted of the cost-effectiveness of quadrivalent vaccine programmes, establishing a maximum incremental total cost per dose of quadrivalent vaccines over trivalent vaccines. With the aid of the quadrivalent influenza vaccines, it would be possible to bring significant health benefits. This was attributed to the vaccines being cost-effective in particular target groups.